Top Markets
#1 Islamic Coin Islamic Coin +151.48%
#2 DOVU DOVU +48.35%
#3 Velvet Velvet +35.55%
#4 Black Phoenix Black Phoenix +34.64%
#5 Akedo Akedo +31.02%
#6 Cross Cross +19.08%
#7 Cap Cap +15.07%
#8 DoubleZero DoubleZero +14.72%
#9 Fake World Assets Fake World Assets +10.11%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.07%
Coin of the day
Islamic Coin Islamic Coin
設定
言語
日本
通貨
USD
テーマ
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
株式のランク #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
株価
$0.0202
最終同期: 2024-11-19
時価総額
$44.67K
変化（1日）
-0.49%
変化（1年）
0.00%
国
IL
取引 Notable Labs, Ltd. (NTBL)

カテゴリー

Healthcare
Notable Labs, Ltd.（NTBL）のP/S比率
August 2026 時点のP/S比率 TTM: 7.72
Notable Labs, Ltd. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 7.72 です。2022 年末時点でのP/S比率は 1.16K でした。
Notable Labs, Ltd. の P/S 比率の履歴（2015 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
2026 (TTM) 7.72 -41.88%
2023 13.29 -98.86%
2022 1.16K -93.42%
2021 17.67K 387.47%
2020 3.63K -4.00%
2019 3.78K 97.37%
2018 1.91K 289.61%
2017 491.09 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 27.92%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 33.38%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -35.54%
BE